Clinical trial

Acitretin and Etanercept in Psoriasis

NCT00156247 · University of Medicine and Dentistry of New Jersey, Other · Completed

Key facts

NCT number NCT00156247
Title Acitretin and Etanercept in Psoriasis
Official title Pilot, Single-Arm Study of the Effect of Adding Acitretin to Etanercept Therapy in Patients With Moderate to Severe Psoriasis Who Fail to Respond to Etanercept Monotherapy
Lead sponsor University of Medicine and Dentistry of New Jersey, Other
Collaborators Connetics Corp.
Status Completed
Phase Phase 2
Study type Interventional
Conditions Psoriasis
Intervention type Drug
Interventions acitretin
Enrollment 10
Start date Sep 1, 2005
Primary completion Mar 1, 2009
Completion Mar 1, 2009
First posted Sep 12, 2005
Last update posted Feb 16, 2015

At a glance

  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies